Cartesian Therapeutics

We are proud to have participated in the MGFA Scientific Session at #AANEM. To learn more about the retreatment data we presented: bit.ly/3VmWmWl We look forward to topline results from our Phase 3 AURORA trial in 1Q27. #CellTherapy #Autoimmunity #RareDisease

Meet us during the MGFA Scientific Session at #AANEM in Orlando and attend our presentation of Descartes-08 retreatment data following a full treatment course in the Phase 2 portion of the study supporting our ongoing Phase 3 AURORA trial in #MG. bit.ly/4ALehX5

Tune in tomorrow at 1:30 pm ET to hear our fireside chat at the H.C. Wainwright & Co. 28th Annual Global Investment Conference. Listen to the webcast here: bit.ly/3UMAenY #celltherapy #autoimmunity

Tune in tomorrow at 3:55 pm ET to hear our fireside chat at the Cantor Global Healthcare Conference. Listen to the webcast here: bit.ly/4xjyXT8 #celltherapy #autoimmunity

Today, we reported second quarter 2026 financial results and provided a business update. Read the full press release here: bit.ly/3RvJdsE #celltherapy #autoimmunity

We’re excited to announce a strategic licensing agreement with WestGene Biopharma to advance the development of novel in vivo chimeric antigen receptor T-cell (CAR-T) therapies in #autoimmune diseases. Read more: bit.ly/4vxjVZi

We are excited to announce we entered into an agreement with K2 HealthVentures to provide a credit facility of up to $150 million, extending cash runway into 2028. We also announced progress and updated timelines for all ongoing trials. Read more: bit.ly/4dNkOpA

Tune in tomorrow at 3:00 pm ET to hear our fireside chat at the H.C. Wainwright 4th Annual BioConnect Nasdaq Investor Conference. Listen to the webcast here: bit.ly/4wmjkLl #celltherapy #autoimmunity

Our team is on the ground at the @ASGCTherapy 2026 Annual Meeting kicking off tomorrow. Come see our posters to hear more about our work in #myastheniagravis. #celltherapy #autoimmunity

Today we reported first quarter 2026 financial results and provided a business update. Full press release: bit.ly/425CDL2 #celltherapy #autoimmunity